Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.04
Oct 20 • 3:59 PM ET Dollar change+0.02 Percentage change(0.66%)
Aftermarket Close
3.04
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
140.36M
Enterprise Value
135.38M
Income
-1.82M
Sales
45.11M
Book/sh
0.39
Cash/sh
0.18
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
73
IPO
Apr 05, 1994
P/E
-
Forward P/E
147.22
PEG
-
P/S
3.11
P/B
7.77
P/C
16.93
P/FCF
179.95
EV/EBITDA
-
EV/Sales
3.00
Quick Ratio
2.09
Current Ratio
2.72
Debt/Eq
0.18
LT Debt/Eq
0.15
Option/Short
Yes / Yes
EPS (ttm)
-0.04
EPS next Y
0.02
EPS next Q
-0.02
EPS this Y
34.88%
EPS next Y
152.85%
EPS next 5Y
-
EPS past 3/5Y
33.31% -14.59%
Sales past 3/5Y
13.81% 11.21%
EPS Y/Y TTM
60.02%
Sales Y/Y TTM
22.41%
EPS Q/Q
213.33%
Sales Q/Q
18.15%
Insider Own
6.76%
Insider Trans
2.00%
Inst Own
55.62%
Inst Trans
-0.35%
ROA
-6.80%
ROE
-10.52%
ROIC
-8.75%
Gross Margin
60.67%
Oper. Margin
-3.66%
Profit Margin
-4.03%
SMA20
-0.07%
SMA50
-4.02%
SMA200
-26.24%
Trades
Shs Outstand
46.15M
Shs Float
43.05M
52W High
6.61 -54.00%
52W Low
2.86 6.29%
Volatility
4.90% 4.94%
ATR (14)
0.14
RSI (14)
45.41
Beta
0.47
Rel Volume
0.44
Avg Volume
245.84K
Volume
108,366
Perf Week
1.33%
Perf Month
-5.88%
Perf Quarter
-21.24%
Perf Half Y
-24.38%
Perf YTD
-47.68%
Perf Year
-26.57%
Perf 3Y
28.81%
Perf 5Y
15.15%
Perf 10Y
641.28%
Prev Close
3.02
Price
3.04
Change %
0.66%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KALBERMATTEN ADAM RChief Commercial OfficerSep 08 '26Buy3.1632,000101,120394,017Sep 09 04:32 PM
KALBERMATTEN ADAM RChief Commercial OfficerJul 28 '26Option Exercise0.0075,0000387,500Aug 06 04:11 PM
KALBERMATTEN ADAM ROfficerAug 03 '26Proposed Sale4.2625,483108,629Aug 03 05:18 PM
KALBERMATTEN ADAM RPresident-Chief Commercial OffJun 11 '26Buy3.9412,50049,275312,500Jun 15 04:34 PM
Schiller EricChief Technology OfficerMay 18 '26Buy3.915,00019,5625,000May 20 04:41 PM
Tharby Linda MChief Executive OfficerMay 15 '26Buy3.901,1914,645620,622May 20 04:02 PM
Tharby Linda MChief Executive OfficerMay 14 '26Option Exercise0.0013,9770626,757May 19 05:08 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Option Exercise0.005,3270310,458May 18 04:39 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Buy3.885,00019,400305,131May 18 04:35 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Option Exercise0.008,1930316,340May 18 04:33 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Buy3.865,50021,248308,147May 18 04:31 PM
Tharby Linda MOfficerMay 14 '26Proposed Sale3.957,32628,915May 14 05:01 PM
Pazdan ChristopherChief Operating OfficerMar 16 '26Option Exercise0.005,06405,064Mar 18 04:47 PM
Adams Thomas EdwardChief Financial OfficerMar 16 '26Option Exercise0.005,40405,404Mar 18 04:45 PM
Tharby Linda MChief Executive OfficerMar 16 '26Option Exercise0.0015,968015,968Mar 18 04:42 PM
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
President & CEOMr. Adam Kalbermatten
CFOMr. Thomas Adams
Chief Operating OfficerMr. Christopher Pazdan
Chief Technology OfficerMr. Eric Schiller